Selected References:

  • Berge LN, et al. 1996. Pregnancy related changes in some cardiovascular risk factors. Acta Obstet. Gynecol. Scand. 75 pp. 439–442.
  • France M, et al. 2016. HEART UK statement on the management of homozygous familial hypercholesterolaemia in the United Kingdom. Atherosclerosis. 255:128-139.
  • Goldberg AC et al. 2011. Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel onFamilial Hypercholesterolemia. J Clin Lipidol. 2011 Jun;5(3 Suppl):S1-8.
  • Jiang S et al. 2017. Maternal dyslipidemia during pregnancy may increase the risk of preterm birth: A meta-analysis. Taiwan J Obstet Gynecol.  56(1):9-15.
  • Moayeri M, et al. 2017. Maternal lipid profile and the relation with spontaneous preterm delivery: a systematic review. Arch Gynecol Obstet.  295(2):313-323.
  • Ogura et al. Lipoprotein apheresis is essential for managing pregnancies in patients with homozygous familial hypercholesterolemia: Seven case series and discussion. Atherosclerosis. 254:179-183.
  • Pugh et al. 2017. Preconception maternal lipoprotein levels in relation to fecundability. Hum Reprod.15:1-9.
  • Schisterman EF,et al. 2014. Lipid concentrations and couple fecundity: the LIFE study. J Clin Endocrinol Metab.99(8):2786-94.
  • Schisterman EF, et al. 2014. Lipid concentrations and semen quality: the LIFE study. Andrology.  2(3):408-15.
  • Toleikyte I, et al. 2011. Pregnancy outcomes in familial hypercholesterolemia: a registry-based study. Circulation. 124(15):1606-14.
  • Varnier NA, et al. 2015. Coronary artery disease secondary to familial hypercholesterolaemia: An infrequent cause of increasingly common pregnancy co-morbidity. Obstet Med.8(3):152-4.
  • Wang C, et al. 2016. The associations between early pregnancy lipid profiles and pregnancy outcomes. J Perinatol.
  • Whitfield M, et al. 2015. Posttesticular sperm maturation, infertility, and hypercholesterolemia. Asian J Androl.  17(5):742-8.